SYK

Stryker Corporation

SYK, USA

Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

https://www.stryker.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
SYK
stock
SYK

Texas Permanent School Fund Corp Sells 13,204 Shares of Stryker Corporation $SYK MarketBeat

Read more →
SYK
stock
SYK

Stryker Corporation $SYK Shares Sold by Nomura Holdings Inc. MarketBeat

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$428.9645

Analyst Picks

Strong Buy

13

Buy

9

Hold

9

Sell

1

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Very Low

48.09

Low 50

High 10

Price to Book Ratio (P/B)

-

Very High

6.29

Low 1

High 3

Return on Equity (ROE)

-

Very Low

3.94 %

Low 5%

High 25%

Return on Assets (ROA)

-

Very Low

1.83 %

Low 2%

High 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

22.34 %

Low 5%

High 15%

Debt to Equity

-

Very Low

1.16

Low 1

High 0.3

Investors

* Institutions hold a combined 66.09% of the total shares of Stryker Corporation

1.

Vanguard Group Inc

(8.7627%)

since

2025/06/30

2.

BlackRock Inc

(6.9647%)

since

2025/06/30

3.

Greenleaf Trust

(4.3654%)

since

2025/06/30

4.

State Street Corp

(3.9122%)

since

2025/06/30

5.

JPMorgan Chase & Co

(3.1986%)

since

2025/06/30

6.

T. Rowe Price Associates, Inc.

(3.1123%)

since

2025/06/30

7.

Vanguard Total Stock Mkt Idx Inv

(2.8255%)

since

2025/07/31

8.

Vanguard 500 Index Investor

(2.227%)

since

2025/07/31

9.

Geode Capital Management, LLC

(1.9339%)

since

2025/06/30

10.

FMR Inc

(1.871%)

since

2025/06/30

11.

Capital Research Global Investors

(1.7699%)

since

2025/06/30

12.

Morgan Stanley - Brokerage Accounts

(1.627%)

since

2025/06/30

13.

AllianceBernstein L.P.

(1.4639%)

since

2025/06/30

14.

Wellington Management Company LLP

(1.4542%)

since

2025/06/30

15.

Bank of New York Mellon Corp

(1.2827%)

since

2025/06/30

16.

Fundsmith Equity I Acc

(1.2461%)

since

2025/03/31

17.

NORGES BANK

(1.2444%)

since

2025/06/30

18.

Fundsmith LLP

(1.2234%)

since

2025/06/30

19.

Fidelity 500 Index

(1.1404%)

since

2025/07/31

20.

SPDR® S&P 500® ETF

(1.087%)

since

2025/08/31

21.

iShares Core S&P 500 ETF

(1.0826%)

since

2025/08/31

22.

Bank of America Corp

(1.0397%)

since

2025/06/30

23.

Vanguard Growth Index Investor

(0.9556%)

since

2025/07/31

24.

Fisher Asset Management, LLC

(0.9025%)

since

2025/06/30

25.

Northern Trust Corp

(0.8971%)

since

2025/06/30

26.

Franklin Resources Inc

(0.8778%)

since

2025/06/30

27.

First Western Trust Bank

(0.8513%)

since

2025/06/30

28.

Vanguard Dividend Growth Inv

(0.8359%)

since

2025/06/30

29.

The Health Care Select Sector SPDR® ETF

(0.6143%)

since

2025/08/31

30.

Vanguard Institutional Index I

(0.5439%)

since

2025/07/31

31.

AllianceBernstein US L/C Growth Eqty MF

(0.5272%)

since

2025/07/31

32.

Capital Group Growth Fnd of Amer Comp

(0.5227%)

since

2025/06/30

33.

American Funds Growth Fund of Amer A

(0.5227%)

since

2025/06/30

34.

Franklin Rising Dividends A

(0.5153%)

since

2025/07/31

35.

American Funds Capital World Gr&Inc A

(0.4922%)

since

2025/06/30

36.

Capital Group World Growth & Inc Cmp

(0.4922%)

since

2025/06/30

37.

Vanguard Dividend Appreciation ETF

(0.4829%)

since

2025/07/31

38.

State St S&P 500® Indx SL Cl III

(0.4802%)

since

2025/08/31

39.

JPMorgan US Equity L

(0.3756%)

since

2025/07/31

40.

Parnassus Core Equity Investor

(0.3667%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

4.39

Latest Release

Date

2025-09-30

EPS Actual

3.19

EPS Estimate

3.13

EPS Difference

0.06

Surprise Percent

1.9169%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4)
Defensive
Highly Defensive(7)
Dividend
Decent Dividend Payer(3.5)
Economic Moat
Wide Moat Company(7.3)
GARP
Not Attractive for GARP(3)
Growth
Weak Growth Prospect(3)
Momentum
Moderate Momentum(4.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(5.5)
Value
Overpriced(3)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.